Eric Ducasse (University of Bordeaux, Bordeaux, France) spoke with Vascular News at this year’s Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany) on the use of artificial intelligence (AI) in vascular interventions. He said there is potential for AI—and...
 Gianmarco de Donato (Siena, Italy) speaks to Vascular News at Paris Vascular Insights (PVI) 2023 (8–10 November, Paris, France) about acute limb ischaemia (ALI), detailing that his treatment approach has changed considerably over the past 10 years. Nowadays, Donato...
Florian Enzmann (Innsbruck, Austria) speaks to Vascular News about PROMOTE ALI—a prospective, multicentre observational study focused on lower limb ischaemia. Acute limb ischaemia (ALI) is “not very well investigated,” the head of endovascular surgery at the Medical University Innsbruck states,...
 Vascular News caught up with European Society for Vascular Surgery (ESVS) president Ian Loftus (London, UK) at the Vascular for Society of Great Britain and Ireland’s (VSGBI) 2023 annual scientific meeting (VSASM; 22–24 November, Dublin, Ireland) to discuss the...
 “I don’t reflect back enough on how much things have changed,” Cynthia Shortell (Durham, USA) tells Vascular News at the 2023 VEITHsymposium (14–18 November, New York, USA), speaking on the representation of women in vascular surgery over the course...
 Principal investigators of the LIFE-BTK randomised controlled trial delve into the technological improvements underpinning the Esprit drug-eluting resorbable scaffold (DRS; Abbott) from its previous iteration used in the coronaries, while discussing how this trial places this device at the...
 "Despite significant technological improvements since its inception, endovascular repair of abdominal aortic aneurysms (AAAs) is still associated with some of the same problems we experienced nearly 30 years ago," Michel Reijnen (Arnhem, The Netherlands) remarked at the VEITHsymposium 2023...
NOTE: This video is ONLY available to watch in selected countries and geographies  Vascular surgeon Raphael Coscas (Paris, France) and interventional cardiologist, Antoine Sauguet (Toulouse, France) and discuss the design and first results from the RADIANCY premarket clinical study,...
 There is a global interest in assessing whether Metformin, which has a long track record of safety and efficacy, is relatively inexpensive and is taken by millions of people every day for type 2 diabetes, has an effect on...
 Daniel Clair (Vanderbilt University Medical Center, Nashville, USA) speaks to Vascular News at this year’s VEITHsymposium (14–18 November, New York, USA) on deep vein arterialisation with the LimFlow system (LimFlow). The technology aims to fill a treatment gap...
 Lawrence Garcia (St Francis Hospital, New York, USA) speaks to Vascular News at VIVA 2023 (30 October–2 November, Las Vegas, USA) on lessons learned from a series of failed below-the-knee (BTK) trials that preceded the recent “first victory” of...
 Vincent Rowe (University of California Los Angeles, Los Angeles, USA) speaks to Vascular News at VIVA 2023 (30 October–2 November, Las Vegas, USA) on the importance of patient-specific decisions for the management of vascular wounds. He also considers how multidisciplinary...
NOTE: This video is ONLY available to watch in selected countries and geographies  The EffPac trial was a prospective, multicentre, randomised controlled trial (RCT) that enrolled 171 patients of Rutherford category two to four with medium-length femoropopliteal lesions. Patients...
 “The median thrombus age of DVT patients treated in our centre is 14 days – says Dr Andrew Wigham from Oxford University Hospitals. – We know that traditional treatment options such as thrombolytics and other thrombectomy devices are less...
NOTE: This video is ONLY available to watch in selected countries and geographies  The benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) catheter—designed for use in large, calcified vessels (available in 8-12 mm diameter sizes), —were highlighted...
 “A truly novel and potentially groundbreaking treatment strategy for patients with small to mid-sized infrarenal abdominal aortic aneurysms,” is how Michael R. Jaff (Boston, USA) describes the Nectero Endovascular Aortic Stabilization Treatment (Nectero EAST®) System from Nectero Medical in...
NOTE: This video is ONLY available to watch in selected countries and geographies Experts gathered at the Society for Vascular Surgery’s 2023 Vascular Annual Meeting (VAM) in National Harbor, Maryland (June 14–17) to discuss the latest innovation from Shockwave...
 “There is an increasing awareness that we need to get aneurysm sacs to regress after endovascular aneurysm repair ,” Andrew Holden (Auckland, New Zealand) stated during a recent discussion with Michel Reijnen (Arnhem, The Netherlands) on potential solutions in...
At this year’s Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Sabine Steiner (Leipzig, Germany) shared first results from the BEST superficial femoral artery (SFA) pilot study—a prospective, multicentre randomised trial comparing the efficacy and safety of a...
 In an interview with Venous News at this year’s Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Raghu Kolluri (Columbus, USA) outlines the “vast list” of options that are now available for the treatment of patients who require...
Why is clot removal crucial for patients suffering from DVT? What are the major benefits of a lytic-free thrombectomy? Watch Michael Lichtenberg (Arnsberg, Germany) present the outcomes of the Arnsberg ClotTriever Study which confirms the safety and efficacy of...
“It is time to question whether patients with end-stage below-the-knee peripheral arterial disease should not be treated primarily with deep vein arterialisation,” Arne Schwindt (Münster, Germany) avers in an interview with Vascular News. Schwindt was speaking at this year’s Leipzig...
A temporary mechanical support with antiproliferative properties might combine two particular treatment qualities to fill a gap in the treatment armamentarium for peripheral arterial disease, both above and below the knee. Ramon Varcoe (Sydney, Australia) moderates a panel with...
NOTE: This video is ONLY available to watch in selected countries and geographies The combined use of a drug-eluting device and a vascular scaffold “seems to be, in the longer run, the perfect solution for complex lesion treatment”. This...
 Eric Secemsky (Boston, USA) and Edward Choke (Singapore) discuss the role of sirolimus-coated balloons in the treatment of peripheral arterial disease (PAD), particularly below the knee, at the Charing Cross (CX) Symposium (25–27 April, London, UK). With high amputation and...
Following his first-to-podium presentation on statin treatment after aortic repair at the 2023 Charing Cross (CX) International Symposium (25–27 April, London, UK), Kevin Mani (Uppsala, Sweden) joined Janet Powell (London, UK) at the CX Vascular Live studio to discuss...
“I see a future where this technology may be used to treat people early and avoid the devastating long term consequences of venous insufficiency” Ramon Varcoe (Sydney, Australia) opined in a CX Vascular Live discussion with Erin Murphy (Charlotte,...
  Konstantinos Spanos (Larissa, Greece) recently shared new meta-analysis data from comparative studies evaluating balloon-expandable versus self-expandable stent grafts for branched endovascular aneurysm repair (BEVAR). Following his first-to-podium presentation at the 2023 Charing 2023 Charing Cross (CX) International Symposium (25–27...
NOTE: This video is ONLY available to watch in selected countries and geographies Could drug-coated balloons (DCBs) be “the perfect device” for the treatment of patients with neointimal hyperplasia? Yes, opines Matteo Tozzi (University of Insubria, Varese, Italy) at...
 A recent study has concluded that the “novel” technique of serration angioplasty with the Serranator balloon (Cagent Vascular) for the treatment of chronic limb-threatening ischaemia (CLTI) in the pedal arteries is “safe and effective”. Following his presentation of this...
Steven Abramowitz (Washington DC, USA) explains the significance of the CLOUT registry—the only registry capturing data on mechanical thrombectomy in deep venous thrombosis (DVT). CLOUT confirms excellent safety results and effectiveness of the ClotTriever system in real-world DVT patients....
  Artificial intelligence (AI) is “here to stay”. This was the closing statement from Randy Moore (Calgary, Canada), vascular surgeon and chief medical officer (CMO) of ViTAA Medical Solutions, during a recent CX Vascular Live roundtable discussion. Moore was joined...
A question from Manj Gohel (Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK) on what the Charing Cross (CX) audience should take back to their multidisciplinary team meetings from the first-time presentation of BASIL-2 led chief investigator Andrew Bradbury...
 “When you save a limb, you save a life” Marianne Brodmann (Graz, Austria) tells CX Live. There are many people who never get seen by a vascular specialist as often there is not a great deal of knowledge among...
 Joseph Coselli (Houston, USA) reflects on the return of in-person meetings and the value they offer in terms of exchanging new information, learning from other healthcare professionals, expanding collective knowledge of the field and ultimately “improving what physicians can...
 Tilo Kölbel (Hamburg, Germany) speaks to CX Live about new, innovative developments within devices and recent results of large studies producing data that poses “interesting” updates to the field of vascular surgery. Focusing in on the aortic community and areas...
 Palma Shaw (Syracuse, USA) discusses how the World Federation of Vascular Societies (WFVS) collaborates to determine what the key needs for trainees and education across the world are. “We bring global vascular societies together and engage in projects in...
 Barbara Rantner (Munich, Germany) talks about the “fantastic experience” of being back in person at CX 2022, where she notes that attendees were able to “meet experts from all over the world” and discuss relevant issues “not only from...
 A range of experts, including Koen Deloose (Dendermonde, Belgium), Thomas Zeller (Bad Krozingen, Germany), Marianne Brodmann (Graz, Austria) and Antonio Micari (Messina, Italy), talk to Vascular News about how the latest data supporting the cost-effectiveness of the IN.PACT Admiral drug-coated balloon...
 Koen Deloose (Dendermonde, Belgium) talks to Vascular News about the key one-year data from the BIOPACT randomised controlled non-inferiority trial, which evaluated the safety and efficacy of the Passeo-18 Lux drug-coated balloon (DCB) catheter (Biotronik) compared to the IN.PACT Admiral...
 Michel Reijnen (Arnhem, The Netherlands) presents the results of a study that sought to assess the potential cost-effectiveness of a urea-based drug-coated balloon (DCB; IN.PACT Admiral, Medtronic) as standard of care treatment for those with chronic limb threatening ischaemia...
 Speaking to CX Live, Eric Secemsky (Boston, USA) delves into the emerging use of intravascular ultrasound (IVUS) in the peripheral procedural phases—outlining contemporary studies providing evidence of its benefit, such as the reduction of restenosis risk when IVUS is...
 As the new kid on the block, endovascular treatment of the common femoral artery (CFA) just does not have that long-term outcome data yet,” Narayanan Thulasidasan (London, UK) tells Vascular News. Thulasidasan discusses some of the benefits of endovascular therapy...
 Giacomo Isernia (Perugia, Italy) sits down with Vascular News to discuss the challenges posed by calcium when it comes to endograft delivery. Calcium “limits the ability to choose the proper graft for each patient,” states Isernia. “This is a pity as...
Treatment of common femoral artery (CFA) stenosis, either with an open or endovascular approach, is the subject of much debate, Raphaël Coscas (Paris, France) tells Vascular News at the Paris Vascular Insights (PVI) conference (23–25 November 2022, Paris, France). “Open surgery...
 Bella Huasen (Preston, UK) talks to Vascular News about some of the difficulties of treating occlusive disease in the femoropopliteal segment and why it is “essential to have tools that will allow you to deal with these challenges”. Huasen outlines some of...
 David Gillespie (Boston, USA) talks to Vascular News about the PRESERVE study—established by the Society for Vascular Surgery and Society of Interventional Radiology—which is the largest prospective study to investigate real-world outcomes with contemporary use of inferior vena cava...
NOTE: This video is ONLY available to watch in selected countries and geographies Robert Shahverdyan (Hamburg, Germany), Matteo Tozzi (Varese, Italy), Alexandros Mallios (Paris, France), Ounali Jaffer (London, UK) and Narayan Karunanithy (London, UK) each give their take on...
NOTE: This video is ONLY available to watch in selected countries and geographies  Iliac side branch devices (ISBs) are “gamechangers in infrarenal therapy of abdominal aortic aneurysms (AAAs),” Mario Lescan (Tübingen, Germany) tells Vascular News. Lescan states that ISBs “allow...
NOTE: This video is ONLY available to watch in selected countries and geographies  In this Vascular News roundtable, Andrew Holden (moderator; Auckland, New Zealand) is joined by Alexandros Mallios (Paris, France), Kate Steiner (Stevenage, UK) and Tobias Steinke (Düsseldorf, Germany) who...
At the 2022 Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (23–25 November, Brighton, UK), Srinivasa Rao Vallabhaneni (University of Liverpool, Liverpool, UK) delivered a first-time presentation of the UK-COMPASS study results. In this interview with Vascular News,...
The UK’s national abdominal aortic aneurysm (AAA) screening programme is fast approaching its 10th anniversary—a milestone that Akhtar Nasim (Sheffield Vascular Institute, Sheffield, Sheffield, UK) and Meryl Davis (Royal Free London NHS Foundation Trust, London, UK) believe provides an...
NOTE: This video is ONLY available to watch in selected countries and geographies Ulf Teichgräber (Jena, Germany) talks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain), about some of...
NOTE: This video is ONLY available to watch in selected countries and geographies “Patients who are on chronic dialysis really depend on arteriovenous (AV) access for their treatment,” Michael Lichtenberg (Arnsberg, Germany) tells Vascular News at the Cardiovascular and Interventional Radiological...
 During a late-breaking clinical trials session at the 2022 Vascular Interventional Advances (VIVA) conference (31 October–3 November, Las Vegas, USA), Mehdi Shishehbor (University Hospitals Harrington Heart & Vascular Institute, Cleveland, USA) presented a patient-level, propensity-adjusted comparison of drug-coated balloons...
 Thomas Maldonado (New York University Medical Center, New York, USA) speaks to Vascular News at the 2022 Vascular Interventional Advances (VIVA) conference (31 October–3 November, Las Vegas, USA) about how new interim data from the STRIDE study will impact...
NOTE: This video is ONLY available to watch in selected countries and geographies Matteo Tozzi (Varese, Italy) speaks to Vascular News at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) about new analysis...
 Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) about some of the difficulties associated with treating patients with pulmonary embolism...
 Ulf Teichgräber (Jena, Germany) and Edward Choke (Singapore) discuss—at the 2022 Charing Cross (CX) International Symposium (26–28 April, London, UK)—some of the key benefits of sirolimus-coated balloons and the key differences between these devices and ones coated with paclitaxel. One...
NOTE: This video is ONLY available to watch in selected countries and geographies  Said Abisi (London, UK) discusses inner branched endovascular aneurysm repair (iBEVAR) technology, which he describes as a good alternative to fenestrated EVAR (FEVAR) and side branches...
NOTE: This video is ONLY available to watch in selected countries and geographies Thomas Zeller (Bad Krozingen, Germany) talks to Vascular News about the iliCo study, of which he is co-principal investigator, and which is designed to evaluate the...
 Andrew Wigham (Oxford, UK) and Rick De Graaf (Friedrichshafen, Germany) discuss the current state of deep vein thrombosis (DVT) treatment at the Leipzig Interventional Course (LINC) 2022 (6–9 June, Leipzig, Germany), with both noting that “a massive problem” in...
 Andrew Holden (Auckland, New Zealand) and Michel Reijnen (Arnhem, The Netherlands) discuss Shape Memory Polymer (Shape Memory Medical)—a porous scaffold that, according to Holden, due to a high volume of surface area, provides “a high level of stasis and...
NOTE: This video is ONLY available to watch in selected countries and geographies  Endologix president and CEO, Matt Thompson (Irvine, USA), discusses how the firm has “been transformed from a company purely focusing on the infrarenal aorta to a...
 “Vascular surgery is my DNA”, Alan Lumsden (Houston, USA) tells Vascular News, as he discusses the role of vascular surgeons in the cardiac surgery world. He highlights that on his programme, “three out of five of our last finishing trainees...
 Intravascular Lithotripsy (IVL; Shockwave Medical) gives physicians “the option to treat a patient efficiently without implanting something like a stent, which would limit further treatment,” Enrique Alejandre Lafont (St Gallen, Switzerland) tells Vascular News at the 2022 Charing Cross (CX)...
 Raphaël Coscas (Paris, France) talks to Vascular News about his introduction to Intravascular Lithotripsy (IVL; Shockwave Medical) and his initial experiences with the technology in treating patients with heavily calcified lesions. Speaking at the 2022 Charing Cross (CX) International Symposium...
NOTE: This video is ONLY available to watch in selected countries and geographies In a late-breaking Podium 1st presentation at the 2022 Charing Cross (CX) International Symposium (26–28 April, London, UK), Andrew Holden (Auckland, New Zealand) revealed that patients...
NOTE: This video is ONLY available to watch in selected countries and geographies Marianne Brodmann (Medical University of Graz, Division of Angiology, Austria) talks about the clinical results of the EMINENT randomised controlled trial, arguing that drug-eluting stents (DES)...
NOTE: This video is ONLY available to watch in selected countries and geographies Gunnar Tepe (interventional radiologist, Germany) discusses the results and subsequent impact of the EMINENT randomised controlled trial on his practice, explaining that the Eluvia stent has...
NOTE: This video is ONLY available to watch in selected countries and geographies  Koen Deloose (vascular surgeon, Belgium) looks at the evidence needed in order to make the best decision for his patients when treating the superficial femoral artery (SFA)....
NOTE: This video is ONLY available to watch in selected countries and geographies Antonio Micari (interventional cardiologist, Italy) gives his thoughts on the EMINENT RCT and whether it may have influenced his decision to use drug-eluting stents and drug...
NOTE: This video is ONLY available to watch in selected countries and geographies  Yann Goueffic (vascular surgeon, France) discusses the evidence that is needed for the best treatment strategy of the femoropopliteal segment. He examines a range of stents,...
 Said Abisi (London, UK) talks to Vascular News about the various treatment options for peripheral arterial disease (PAD) patients with severely calcified lesions, including plain percutaneous transluminal angioplasty (PTA), stenting or atherectomy. “None of these come without risk” notes...
 Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System (Medtronic), how it compares to more traditional fistula creation techniques, and the key steps for...
The new Vascular Society of Great Britain and Ireland (VSGBI) president Jonathan Boyle (Cambridge, UK) speaks to Vascular News about his plans for the coming year. The promotion of key messages in the newly published Provision of Services for People with...
 The Amplifi Vein Dilation System (Artio Medical) is is an innovative device designed to dilate arm veins in preparation for AVF surgery using rapid, non-pulsatile venous blood flow. Surendra Shenoy, M.D. (a vascular surgeon with specialist interest in vascular...
 Isabelle Van Herzeele (Ghent, Belgium) and Adrien Hertault (Valenciennes, France) speak about the importance of face to face training sessions for trainee physicians and physicians in practice. The pair tells Vascular News at the Paris Vascular Insights meeting (21–23 October...
 Artificial intelligence (AI) will transform the accuracy of patient selection and endograft selection for aortic procedures. Its use will shore up computed tomography (CT) scan analysis and comparison, not just when tracking maximum aortic diameters at the various segments...
 In this penultimate episode of a special five-part series on the history of drug-coated balloons (DCBs), Jos van den Berg (Lugano, Switzerland) is joined by Gunnar Tepe (Rosenheim, Germany) and Thomas Zeller (Bad Krozingen, Germany), with the trio discussing...
NOTE: This video is ONLY available to watch in selected countries and geographies  Bruno Migliara (Peschiera del Garda, Italy) talks to Vascular News about the reasons why bypass failure, which he notes is “really dangerous for life and limb”, is so...
Luca Bertoglio (Milan, Italy) moderates a Vascular News roundtable on the new E-nside TAAA stent graft system (CryoLife) which has been designed for the treatment of thoracoabdominal aneurysms and uses inner branch technology. Bertoglio is joined by Vladimir Makaloski...
Brian DeRubertis (Los Angeles, USA) talks to Vascular News about the benefits and challenges of starting and running an office-based lab (OBL), which he outlined during his presentation at the recent Pacific Northwest Endovascular Conference (PNEC, 27–28 May, Seattle, USA). There are...
In this third episode of a special five-part series on the history of DCBs, Jos van den Berg (Lugano, Switzerland) moderates a Vascular News roundtable discussion where he is joined by John Laird (St Helena, USA) and Peter Schneider (San Francisco,...
 Anna Prent (London, UK) chats to Vascular News at London Aortic Symposium (11–12 October 2018, London, UK), about the need to treat type I endoleaks due to the “high risk of secondary sac perfusion and rupture”. Patients should receive “tailor-made...
Speaking on current trends in amputation rates with critical limb-threatening ischaemia (CLTI) patients, Misty Humphries (Sacramento, USA) tells Vascular News that while Medicare data shows that amputation rates are decreasing across the USA overall, there are “certain geographical areas” that have high rates, with many...
Rupert Bauersachs (Darmstadt, Germany) talks to Cardiovascular News about the VOYAGER-PAD trial, the results of which he presented at the American College of Cardiology’s 70th Annual Scientific Session (ACC.21, 15–17 May, virtual) and which highlighted a reduced risk of...
 Andrew Holden (Auckland, New Zealand) presents the latest results from the IN.PACT™ AV Access trial (Medtronic), which indicate “outstanding” target-lesion primary patency rates of 52.2% through 24 months in dialysis patients with dysfunctional arteriovenous fistulas (AVFs), offering a “highly-significant advantage” over standard...
 Tilo Kölbel (Hamburg, Germany; moderator) is joined by Geert Willem Schurink (Maastricht, Netherlands) and Joost van Herwaarden (Utrecht, Netherlands) in this Vascular News roundtable, titled Bringing 3D device guidance into the hybrid lab with Fiber Optic RealShape (FORS) technology. FORS...
NOTE: This video is ONLY available to watch in selected countries and geographies  Robert Rhee (New York, USA) moderates a Charing Cross 2021 webinar–A deep dive in the GORE® ACTIVE CONTROL System–where he is joined by Robin Heijmen (Nieuwegein,...
 “Not all Drug-Coated Balloons (DCBs) are created equal”, Juan Granada (New York, USA), tells Vascular News in this second episode of a five-part series on the history of DCBs. Granada discusses why there are differences in these devices, noting that some have a longer term retention of drug,...
NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor drug-coated balloon (DCB; iVascular) in different indications. He is joined by Tjun Tang (Singapore) and...
NOTE: This video is ONLY available to watch in selected countries and geographies Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor drug-coated balloon (DCB; iVascular) in different indications. He is joined by Tjun Tang (Singapore) and...
NOTE: This video is ONLY available to watch in selected countries and geographies  Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor drug-coated balloon (DCB; iVascular) in different indications. He is joined by Tjun Tang (Singapore) and...
 Gianmarco de Donato (Siena, Italy) discusses the findings from the INDIAN registry, which were presented during CX 2021 (Charing Cross Symposium; 19–22 April, online) and were recently published in the European Journal of Vascular and Endovascular Surgery. The registry sought...
Patrick Kelly (Sioux Falls, USA) and Peter Schneider (San Francisco, USA) discuss a novel technology from BlueDop Medical that uses a patented process to determine ankle blood pressure from a simple Doppler signal “without a blood pressure cuff at...
 The Altura™ Endograft System (Lombard Medical) is an “outstanding leap forward”, Jörg Teßarek (Lingen, Germany) tells Vascular News, while describing his experience with the both the standard and fenestrated Altura™ devices. Teßarek draws particular attention to the main features of...
NOTE: This video is ONLY available to watch in selected countries and geographies  Sabine Steiner (Leipzig, Germany) sits down with Michael Jaff, the CMO & VP of Boston Scientific, USA, to discuss the two-year results from the COMPARE trial,...
 William Jeffcoate (Nottingham, UK) discusses his upcoming presentation at the Hurting Leg session at CX 2021, titled The impact of socio-economic and clinical variables on the incidence of major amputation in people with diabetic foot ulcers. The session, which...
 To mark the 20-year anniversary of drug-coated balloons, Bruno Scheller (Homburg/Saar, Germany) and Gunnar Tepe (Rosenheim, Germany), talk to Vascular News about their contributions to the birth and evolution of these devices. Scheller discusses his work in the 1990s with...
NOTE: This video is ONLY available to watch in selected countries and geographies Tobias Steinke (Düsseldorf, Germany), Matteo Tozzi (Varese, Italy) and Robert Shahverdyan (Hamburg, Germany) give their reactions to the publication in the New England Journal of Medicine...
NOTE: This video is ONLY available to watch in selected countries and geographies Ralf Langhoff (Berlin, Germany) talks to Vascular News about the 12-month data from the CONSEQUENT study, which aims to assess the safety and efficacy of the SeQuent®...
Raghu Kolluri (Columbus, USA) talks to Vascular News about a recent comparative study looking at differences between in-tack and in-stent restenosis. The study examined data from the TOBA II trial–specifically 28 patients who had received some form of reintervention–with...
 Kenneth Rosenfield (Boston, USA) speaks to Vascular News about the TRANSCEND trial, a non-inferiority randomised controlled trial, which looked to demonstrate safety and efficacy of the lower-dose third-generation SurVeil drug-coated balloon (DCB; Surmodics) when compared with the IN.PACT Admiral DCB (Medtronic)...
Michel Reijnen (Arnhem, Netherlands) talks to Vascular News about the four-year IN.PACT Global study results, focusing on the 156 patients in the study who had critical limb ischaemia (CLI). These patients had a mean lesion length of 40 centimetres...
 Sabine Steiner (Leipzig, Germany) talks to Vascular News about the 24-month results from the COMPARE trial – which were presented at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) – a trial which compared a low dose paclitaxel-coated...
 Bart Dolmatch (Portola Valley, USA) talks to Vascular News about some of the key data highlights from the 24-month AVeNEW trial, which compared the safety and efficacy of the Covera™ Vascular covered stent (BD) against percutaneous transluminal angioplasty (PTA) for the treatment...
 A trio of vascular experts including Raphaël Coscas (Paris, France), Alexandros Mallios (Paris, France) and Kate Steiner (Stevenage, UK) discuss the key findings of the IN.PACT™ AV Access trial–which was recently published in the New England Journal of Medicine...
 Ruth Benson (Birmingham, UK) and Sandip Nandhra (Newcastle, UK) speak to Vascular News about their presentation on the COVID-19 Vascular Service (COVER) study, which aims to evaluate the evolving impact of the COVID-19 pandemic on vascular practice, using a...
Nicholas Inston (Birmingham, UK; moderator) is joined by Jose Ibeas (Barcelona, Spain), Panagiotis Kitrou (Patras, Greece) and Tobias Steinke (Düsseldorf, Germany), for a special Vascular News webinar called ‘WavelinQ™ 4F EndoAVF System – An attractive non-surgical AV fistula option for...
Athanasios Saratzis (Leicester, UK) speaks to Vascular News about his lecture at VSASM 2020 (Vascular Societies’ Annual Scientific Meeting; 24–27 November, Virtual) on renal injury in major endovascular surgery, arguing that acute kidney injury (AKI) and chronic renal decline...
NOTE: This video is ONLY available to watch in selected countries and geographies Robert Lookstein (New York, USA; principal investigator) and Andrew Holden (Auckland, New Zealand; principal investigator) discuss the key six-month results and implications from the IN.PACT™ AV...
 Sean Lyden (Cleveland, USA), current VIVA Board president, speaks to Vascular News about his two years at the helm, which began with the “controversy on paclitaxel” and has led right up to COVID-19 and the first virtual VIVA meeting. Ten...
Moderate-to-severe calcification in peripheral arteries is an “ongoing battle” in in the endovascular treatment of complex lesions, William Gray (Philadelphia, USA), tells Vascular News. Gray explains that there are a number of tools deployed to win the acute battle, but notes frankly that they...
 “There has been a steady change in the approach and care of pulmonary embolisms that has been noted over the last five to seven years in the US, but also worldwide, and that seems to be spear-headed by a...
Anthony Comerota (Alexandria, USA), global principal investigator of the VIVO trial, discusses the highlights of the 12-month results of the VIVO clinical study that were presented at VIVA 2020. While the safety and efficacy of the Zilver Vena stent, which...
Krishna Rocha-Singh (Springfield, USA) speaks to Vascular News about his presentation at VIVA20 (Vascular Interventional Advances; 6–7 November 2020; virtual) on the REALITY study, which examined the safety and efficacy of directional atherectomy combined with drug-coated balloon to treat...
Karen Woo (Los Angeles, USA) speaks to Vascular News about the Vascular Low Frequency Disease Consortium (VLFDC) following her presentation at the 2020 European Society for Vascular Surgery (ESVS) annual meeting (29 September–29 October, virtual). One of the problems the...
Speaking from four separate rooms in four different corners of the world, William Ennis, Desmond Bell, Michael Edmonds, and William Li expounded over zoom on the myriad ways in which COVID-19 had impacted multidisciplinary wound care, both in terms...
Roberto Chiesa (Milan, Italy), who was at the frontline of the COVID-19 pandemic in the Lombardy region of Italy, shares his team’s experience in tackling vascular and aortic emergencies during this time. Chiesa outlines the response in the region to...
The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this...
Thomas Maldonado and Michael Barfield, both of NYU Langone Health (New York, USA), share their experiences of the coronavirus outbreak and discuss how the skills of vascular surgeons can be best utilised during the COVID-19 pandemic. Maldonado says it is...
Data from an unselected, real-world cohort of 64,000 claimants of the German BARMER Health Insurance reveals no signal of increased long-term mortality when paclitaxel-based devices are used in the femoropopliteal arteries, Eva Freisinger (Münster, Germany) told BLearning Peripheral at...
George Adams, MD (Raleigh, USA) talks to Vascular News at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the six-month data from the TOBA II BTK pivotal study immediately after the late-breaking clinical trial session in which these data were...
George Adams, MD (Raleigh, USA) talks to Vascular News at VIVA 2019 (Vascular InterVentional Advances; 4–7 November, Las Vegas, USA) about the six-month data from the TOBA II BTK pivotal study immediately after the late-breaking clinical trial session in which these data were...
Sophie Renton (London, UK) moderates a session with Michel Makaroun (Pittsburgh, USA) and Armando Mansilha (Porto, Portugal) where the trio discuss some of the challenges relating to recruitment within the field of vascular surgery. Makaroun explains that there are two...
NOTE: This video is ONLY available to watch in selected countries and geographies Andrew Holden (Auckland, New Zealand), Alexandros Mallios (Paris, France), Robert Lookstein (New York, USA) and Tobias Steinke (Dusseldorf, Germany) talk to BLearning Peripheral about the 12-month results...
 Edward Choke (Singapore) talks to BLearning Peripheral at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the first-in-man clinical study—XTOSI—which looked at the safety and efficacy of a sirolimus drug-coated balloon (DCB) in the treatment of peripheral arterial disease. The interim...
 Alberto Muñoz (Bogota, Colombia) talks to BLearning at CX 2019 (Charing Cross Symposium; 15–18 April, London, UK) about how the meeting provides a “great opportunity” to update attendees on the latest in vascular and endovascular surgery. Muñoz goes on to highlight the international flavour...
 Peter Schneider (San Francisco, USA) talks to BLearning Peripheral at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the relevance of dose relationship and geographical data when discussing the controversy surrounding the use of paclitaxel devices in peripheral arterial disease...
 Dierk Scheinert (Leipzig, Germany) moderates a panel with Eva Freisinger (Münster, Germany) and Thomas Zeller (Bad Krozingen, Germany) to discuss the developments over the past 12 months surrounding the safety of paclitaxel. Zeller notes that further analyses of the randomised...
 Venous News filmed a panel discussion with Alun Davies (London, UK), Manj Gohel (Cambridge, UK) and Daniel Carradice (Hull, UK); who discussed treatment of venous ulceration and the randomised EVRA trial which, Carradice says, showed that early endovenous ablation of superficial venous...
 Paul Hayes (Cambridge, UK) talks to BLearning Wounds at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about the challenges of wound care, in particular assessing the success or failure of endovascular treatment of peripheral artery disease,...
The first head-to-head randomised controlled trial to directly compare two different drug-coated balloons—the lower-dose density (2μg/mm2) Ranger and higher-dose density (3.5μg/mm2) IN.PACT—showed similar results with regard to effectiveness and safety through 12 months for femoropopliteal interventions, Dierk Scheinert (Leipzig, Germany)...
Kenneth Ouriel (New York, USA) talks to BLearning Peripheral at LINC 2020 (Leipzig Interventional Course; 28–31 January 2020, Leipzig, Germany) about a recent independent analysis to assess safety outcomes of femoropopliteal drug-coated balloon (DCB) angioplasty using patient-level data from the Lutonix clinical programme–and...
 Recently appointed chair of the Circulation Foundation, Rachel Bell (London, UK), talks to BLearning at VSASM 2019 (Vascular Societies’ Annual Scientific Meeting; 27–29 November, Manchester, UK) about the role of the vascular charity and her plans for its future. Bell, who spoke on both aortic...
 Enrico Ascher (New York, USA) interviews Juan Parodi (Buenos Aires, Argentina) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA), about his research on claudication therapy. Parodi explains how he was able to avoid amputating a patient’s extremity by making the patient drink...
 Sahil Parikh (New York, USA) talks to Brian DeRubertis (Los Angeles, USA) at VEITHsymposium 2019 (19–23 November, New York, USA) about the future of below-the-knee (BTK) interventions, with the latter noting that there is “a lot of excitement” around the...
 Nick Cheshire (London, UK) interviews Hazim Safi (Houston, USA) for VEITHtv at VEITH 2019 (19–23 November, New York, USA) about his early training, which Safi describes as being “like the wild west”. He argues arduous training prevents trainees from learning and believes it is...
NOTE: This video is ONLY available to watch in selected countries and geographies  The one-year IN.PACT AV trial results, first presented at LINC 2020 (28–31 January, Leipzig, Germany), reveal that the target lesion primary patency in the patient group treated with the...
Sean Lyden (Cleveland, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about the “tumultuous” year for the industry following the publication of the 2018 Katsanos meta-analysis which showed an increased mortality risk with the use of paclitaxel-coated balloons at five-years in...
Juan Granada (New York, USA) chats to Sahil Parikh (New York, USA) for VEITHtv about below-the-knee (BTK) intervention and innovation and how the paclitaxel controversy has influenced the treatment of BTK disease. Parikh says: “Frankly there is a lot of dampened enthusiasm”...
Keith Calligaro (Philadelphia, USA) interviews Vikram Kashyap (Cleveland, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about whether transcarotid artery revascularisation (TCAR) might replace carotid endarterectomy (CEA) in the future. Kashyap says that although he has become an “enthusiast” of...
Ali AbuRahma (Charleston, USA) moderates a panel for VEITHtv where he is joined by Mahmoud Malas (San Diego, USA) and Enrico Ascher (New York, USA), to discuss the differing strengths and downsides of transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA). Malas...
George Adams (Raleigh, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about the benefits of using easy-to-use Shockwave IVL (Intravascular Lithotripsy) in calcified below-the-knee vessels, which he says, results in “great outcomes”. Adams explains that calcific plaque, particularly medial...
Enrico Ascher (New York, USA) interviews Mark Farber (Chapel Hill, USA) for VEITHtv at VEITHsymposium 2019 (19–23 November, New York, USA) about the differences between off-the-shelf (OTS) devices and custom manufactured devices (CMD) for complex aneurysm repair. Farber says physicians are faced with a...
Eminent vascular surgeons and interventional cardiologists including Kim Hodgson (Springfield, USA), Ramon Varcoe (Sydney, Australia) and Gary Ansel (Columbus, USA) give their thoughts on the recently released meta-analysis in JVIR, which has suggested an increased risk of death or...
 A range of interventional radiology experts including Michael Dake (Tucson, USA), John Kaufman (Portland, USA), Jim Reekers (Amsterdam, The Netherlands) and Gunnar Tepe (Rosenheim, Germany) give their thoughts on the recently released meta-analysis in JVIR, which has suggested an...
 Watch Andrew Holden (Auckland, New Zealand) present the six-month results of the IN.PACT AV Access trial. The multicentre, prospective, randomised controlled trial shows that treatment with the IN.PACT AV drug-coated balloon (DCB) resulted in 56% fewer target lesion revascularisation procedures...
Ronald Dalman (Stanford, USA) and Kak Khee Yeung (Amsterdam, The Netherlands) talk to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA) about how the use of metformin may help suppress the progression of abdominal aortic aneurysms (AAA). Dalman points out that initial...
Matt Thompson (Irvine, USA) talks to VEITHtv about his role, as chief medical officer at Endologix, in assessing the diverse portfolio of endografts and their performance. Thompson notes that because different endograft designs have different strengths and complications, “it is important to...
 Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–23 November, New York, USA), about the benefits of using Shockwave Intravascular Lithotripsy (IVL) when performing EVAR and TEVAR through calcified iliac arteries. Arko, who shares some of the downsides of traditional procedures...
Christopher Kwolek (Boston, USA) talks to VEITHtv about the “truly revolutionary” LEOPARD trial which evaluated the AFX EVAR AAA Graft System (Endologix) with anatomical fixation against a range of other approved endovascular systems with proximal fixation. The three-year data show that...
Enrico Ascher (New York, USA) interviews endovascular pioneers Juan Parodi (Buenos Aires, Argentina) and Frank Veith (New York, USA) about the early days of endovascular aortic repair (EVAR) for VEITHtv. While Parodi recounts his early quest for a less invasive, less morbid,...
Jan Blankensteijn (Amsterdam, Netherlands) talks to BLearning Aortic at VSASM 2019 (Vascular Societies’ Annual Scientific Meeting; 27–29 November, Manchester, UK) following his Kinmonth Lecture presentation titled ‘The current status of EVAR—Two decades of daydreams and nightmares’. Blankensteijn talks about the highs and lows associated...
Nick Cheshire (London, UK) interviews Andrew Bradbury (Birmingham, UK) for VEITHtv at VEITH 2019 (19–23 November, New York, USA) about the draft National Institute for Health and Care Excellence (NICE) guideline on abdominal aortic aneurysm (AAA) repair. This guideline has been in the centre...
Dominic Foy (Bournemouth, UK), President of the SVT (Society for Vascular Technology of Great Britain & Ireland), talks to BLearning at VSASM 2019 (Vascular Societies’ Annual Scientific Meeting; 27–29 November, Manchester, UK) about the role of the SVT and its aims to promote...
Joost van Herwaarden (Utrecht, The Netherlands) and Tilo Kölbel (Hamburg, Germany) discuss the current challenges of image-guided therapy—primarily regarding the limiting factor of having 2D imaging of a 3D environment, including of the intra-body devices and about the concerns...
Clinically relevant outcomes are needed to measure catheter-directed therapy (CDT) against anticoagulation alone to treat submassive pulmonary embolism (PE) patients. Further, CDT’s ability to affect short-term and long-term outcomes such as cardiopulmonary health after PE needs “better characterisation”, Akhilesh...
Daniel Clair (Columbia, SC, USA), presented positive six-month data from the full patient cohort of the PROMISE I early feasibility study of the LimFlow percutaneous deep vein arterialisation system (LimFlow) as a late-breaking trial at VIVA 2019 (Vascular InterVentional...
Curiously, the mortality risk for patients with critical limb ischaemia (CLI) has not changed over the last few decades, despite advances in cardiovascular medicine that treat myocardial infarction and stroke, the two biggest causes of death in these patients,...
Bruce Gray (Greenville, USA) talks to Vascular News after winning the LIVE (Leader In EndoVascular Education) award at VIVA 2019 (4–7 November, Las Vegas, USA), which he says was “very humbling” and “an honour”. Gray speaks to the challenge of...
Nick Hopkins (Buffalo, USA) talks to BLearning Neuro at VEITH Symposium 2018 (13–17 November 2018, New York, USA) about the DAWN trial (LINK), which showed that in carefully selected acute ischaemic stroke patients that “intervention out to 24 hours is viable”. “Stroke...
Philippe Kolh (Liege, Belgium) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about how the European Society for Vascular Surgery’s (ESVS) plans to disseminate the recently published Global Vascular Guidelines for Chronic Limb Threatening...
 The GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System was launched in the USA at the 2019 SVS Vascular Annual Meeting (VAM; 12–15 June 2019, National Harbor), just weeks after the device obtained FDA approval. Dittmar Böckler (Heidelberg,...
Christian-Alexander Behrendt (Hamburg, Germany) talks to BLearning Peripherial at ESVS 2019 (European Society of Vascular Surgery; 24-27 September 2019; Hamburg, Germany) about an international study that underlines the stark difference between the number of major amputations in countries like Hungary and Slovakia and others,...
Kevin Mani (Uppsala, Sweden) talks to BLearning Aortic at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about a recently published epidemiological analysis of ruptured abdominal aortic aneurysms (AAAs) in Sweden over a twenty-year period. The analysis indicated that the epidemiology of ruptured AAAs is...
Bijan Modarai (London, UK) talks to BLearning Peripheral at ESVS 2019 (European Society for Vascular Surgery; 24–27 September; Hamburg, Germany) about the HT-CLI trial, which will look at the efficacy of a novel blood filtration technology that is aimed at using cells that are...
Jos van den Berg (Lugano, Switzerland) tells Vascular News at CIRSE 2019 that the results of the APERTO AVF China trial provide strong evidence of the benefits of using the APERTO drug-coated balloon (DCB; Cardionovum) in haemodialysis patients who had stenosis of, mainly, de novo...
Caitlin Hicks (Baltimore, USA) talks to BLearning at SVS 2019 (Society for Vascular Surgery; 12–15 June; Washington DC, USA) about why it is so important to save limbs and the huge impact limb salvage can have on a patient’s...
Andrew Holden (Auckland, New Zealand) provides perspective on the first results from the Disrupt PAD III observational registry that were presented at the Charing Cross International Symposium 2019. This large registry is designed to evaluate the use of Intravascular...
 Lorenzo Patrone (London, UK) shares with BLearning at CIRSE 2019 (7–11 September, Barcelona, Spain) the benefits of using the OUTBACK™ Elite Re-entry Catheter (Cordis, a Cardinal Health Company) in chronic total occlusions—in any arterial segment from the iliacs to...
 Julien Hasselmann (Malmö, Sweden) talks to iWounds News at ESVS 2019 (European Society of Vascular Surgery; 24–27 September; Hamburg, Germany) about the recent findings of the INVIPS trial which looked at the effect of negative pressure wound therapy (NPWT)...
NOTE: ONLY intended for healthcare professionals outside of the USA and France. Zoom in on a tête-à-tete between Marianne Brodmann (Graz, Austria) and Giovanni Torsello (Munster, Germany) who talk through the latest clinical evidence that directly compares drug-eluting stents in...
NOTE: ONLY intended for healthcare professionals outside of the USA. Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the EFFPAC trial and the six-month outcomes of the TINTIN trial. Both trials used the luminor...
NOTE: This video is ONLY available to watch in selected countries and geographies   Jos van den Berg (Lugano, Switzerland) speaks to Andrew Holden (Auckland, New Zealand) to distil the headline findings from the first-ever results of the IN.PACT AV access...
 Michael Dake (Tucson, Arizona) presented the two-year data from the VERNACULAR trial at CIRSE 2019 on 8 September in Barcelona, Spain. Dake said: “The 24-month results from the VERNACULAR trial using the BD Venovo stent show absolutely sustained benefit in...
Ali Azizzadeh (Los Angeles, USA) talks to BLearning at SVS 2019 (Society for Vascular Surgery, 12–15 June, Washington DC, USA) about his recent move from Houston, Texas to Los Angeles, California, and how the patient populations differ between these two areas. Azizzadeh has observed...
 Ian Loftus (London, UK), president of the Vascular Society for Great Britain and Ireland, tells BLearning about the most recent developments in the UK’s NICE guidance on abdominal aortic aneurysm. The draft version of the guideline created a furore, when...
𝙏𝙝𝙞𝙨 𝙫𝙞𝙙𝙚𝙤 𝙞𝙨 𝙞𝙣𝙩𝙚𝙣𝙙𝙚𝙙 𝙛𝙤𝙧 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙞𝙣 𝙀𝙪𝙧𝙤𝙥𝙚 𝙤𝙣𝙡𝙮. Giovanni Torsello (Münster, Germany) and Mauro Gargiulo (Bologna, Italy) discuss the “very high” morbidity and mortality caused by open surgery when treating complex aortic aneurysms. This is why, they say,...
Jos van den Berg (Lugano, Switzerland), Antonio Micari (Bergamo, Italy) and Marianne Brodmann (Graz, Austria) sit down after a specially convened US FDA panel reviewed paclitaxel device data, with recommendations still to come. The physicians discuss the safety of...
 Karen Bauer (Toledo, USA) discusses the wound care limb salvage track at C3 which offered the “opportunity for clinicians from multiple disciplines to get together and talk about some really cutting-edge” topics. Bauer, a wound specialist, says that at the...
Rajesh Dave (Camp Hill, USA) talks to iWounds News about his highlights from the 15th annual C3 conference, which included a special session on the paclitaxel controversy. Dave talks about the “journey of 15 years” and how the meeting started...
 Mahmoud Malas (San Diego, USA) presented, for the first time, updated results from the TransCarotid Artery Revascularization (TCAR) Surveillance Project at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM; 12–15 June, National Harbor, USA). Malas distilled the data...
 Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration. Hayes...
 Health technology solutions—such as mobile apps and wearables—can play a huge role in activity tracking and assessing the outcomes of peripheral vascular interventions, says Ronald L Dalman (Stanford, USA), president-elect of the Society for Vascular Surgery (SVS). Down the...
 Kim Hodgson (Springfield, USA), president of the Society for Vascular Surgery (SVS) for 2019–20 spoke to Vascular News at the organisation’s Vascular Annual Meeting in June to share the most influential data to have emerged from the Vascular Quality...
 Dawn Coleman (Ann Arbor, USA) shares headline findings from a Society for Vascular Surgery (SVS) survey that found 41% of 960 respondents met validated metrics for burnout. “Burnout, depression and suicidal ideation represent a very real problem within our...
Andrew Holden (Auckland, New Zealand) and Peter Schneider (San Francisco, USA) discuss the Tack Endovascular System (Intact Vascular) and its impact on below the knee and above the knee procedures at the Charing Cross Symposium 2019. Schneider talks about...
 Watch the video roundup from the CX 2019 Highlight Session, Paclitaxel: The last word. Filmed onsite at the Charing Cross Symposium (15–18 April 2019, London, UK).
Ulf Teichgräber (Jena, Germany), talks to Vascular News at EuroPCR 2019 about the EFFPAC trial which compared the luminor (iVascular) drug-coated balloon (DCB) with plain old balloon angioplasty (POBA). Teichgräber outlines the 24-month results from the trial specifically the secondary...
 Michael Edmonds (London, UK), Thomas Serena (Warren, USA), Keith Harding (Cardiff, UK), and Williams Ennis (Oak Lawn, USA) talk at Charing Cross Live about the first-ever iWounds workshop, the importance of wound management and what they hope to achieve. Edmonds...
Eluvia DES is the only technology that uses polymer-based drug delivery to treat Peripheral Artery Disease (PAD). Its polymer ensures that the majority of drug is delivered to the tissue while minimizing downstream particulates. Boston Scientific has more than...
 Following the latest information presented at the Charing Cross (CX) International Symposium related to the meta-analysis of paclitaxel-coated devices (Katsanos et al), hear from a multi-specialty panel of global experts who are discussing their current practice and the way they...
 At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the value of paclitaxel devices in...
 There were calls for greater transparency and sharing of the available randomised controlled trial data of paclitaxel-coated devices at the CX 2019 Highlight Session, Paclitaxel: The Last Word. The session also emphasised the need for a meta-analysis of individual patient-level data...
This post is sponsored by iVascular  Interview with Vicente Riambau (Hospital Clinic de Barcelona, Spain) about the paclitaxel matter. Are really all the drug-coated balloons the same?
This post is sponsored by iVascular Interview with Koen Deloose (AZ Sint-Blasius, Belgium) about paclitaxel safety and the outcomes of Luminor in different types of lesions.
 Jan Blankensteijn (Amsterdam, The Netherlands; principal investigator of the DREAM trial) tells Vascular News about what inspired him to design the DREAM trial, how its findings became particularly important with the long-term follow-up data for endovascular aneurysm repair (EVAR)...
 Roger Greenhalgh (London, UK), was honoured at the 2018 VEITHsymposium alongside other endovascular aneurysm repair (EVAR) pioneers. He spoke to Vascular News about his conviction in the late 1990s that prospective randomised controlled trials were the way to properly...
 "Paclitaxel kills the cells in the artery wall; sirolimus simply stuns them," says Peter Gaines (Sheffield, UK). Gaines commented at the 2019 Vascular Leaders Forum (VLF; 1–2 March, Washington, DC, USA) on the modes of action of these two...
 Krishna Rocha-Singh (Springfield, USA) tells Vascular News that plans after VLF 2019 include publishing a white paper and expeditiously pooling individual patient-level data from the industry randomised controlled trials for independent statistical analysis. This analysis would validate, or disprove,...
 Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about how drug-based therapies have become a mainstay in femoropopliteal revascularisation and how interventionalists should be using best medical therapy “more than we do ”. He also shares his...
 At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman Jalaie (Aachen, Germany) and Mert Dumantepe (Istanbul, Turkey) share their experiences in treatment of pulmonary embolism, acute and chronic deep venous thrombosis (DVT) using acoustic pulse thrombolysis. This...
 Marianne Brodmann (Graz, Austria) quizzes Michael Lichternberg (Arnsberg, Germany) at LINC 2019 on his choice of tools to identify and repair dissections in both the superficial femoral artery and below the knee. If there is dissection that shows a haemodynamic...
 Nicholas Inston (Birmingham, UK) tells Vascular News at LINC 2019 about the exciting field of percutaneous arteriovenous fistula (AVF) creation, the main devices and trials in the space and the lack of long-term evidence showing AVFs created percutaneously “are still...
 Jihad Mustapha (Grand Rapids, USA) explains how the Temporary Spur stent system (Reflow), which is a spiked self-expanding stent is intended for use in conjunction with a drug-coated balloon, works to help deliver drug to the media or subintima...
 In the arterial space, VIVA 2018 focused on the fact that there is an increasing awareness of limb threatening ischaemia coupled with an increase in interventional tools, but no clear defined pathway for treatment. There is also uncertainty about...
 Dierk Scheinert (Leipzig, Germany) talks to Vascular News at LINC 2019 about the importance of vessel preparation with adjunctive therapies such as the use of the dedicated scoring balloon, ULTRASCORE (BD), prior to the use of a drug-coated balloon...
 Renowned experts expressed confidence in the continued use of paclitaxel-coated devices after independent patient-level data presented at LINC 2019 did not show correlation between paclitaxel exposure and mortality. Findings from Baim (formerly Harvard Clinical Research Institute) are now published in...
 Recent technological advancements, including the use of micromesh stents, greater adoption of proximal protection and new techniques such as transcarotid artery revascularisation (TCAR) are taking the field of carotid artery stenting (CAS) forward. A major advance will be getting reimbursement...
 Sean Lyden (Cleveland, USA) and Fabrizio Fanelli (Rome, Italy) discuss the safety and future of drug-coated balloons (DCB) in light of the latest pooled analysis of patient-level data of over 2,300 patients treated with Philips’ Stellarex DCB in above-the-knee...
 A renowned panel, moderated by Dierk Scheinert (Leipzig, Germany), comprising Peter Schneider (Honolulu, USA), John Laird (St Helena, USA) and Thomas Zeller (Bad Krozingen, Germany) expressed confidence in the continued use of paclitaxel-coated devices after individual patient-level data were...
 Ross Milner (Chicago, USA) spoke to Vascular News at the VEITHsymposium about the importance of long-term data for aortic endografts and the GREAT (Global Registry for Endovascular Aortic Treatment) study—a 5,000 patient real-world dataset that will follow patients out to...
 Stéphan Haulon, member of the CX Aortic Executive Board looks ahead to CX 2019 and raises some of the key questions that will be addressed in the programme.
 The draft Global Vascular Guidelines on chronic limb threatening ischaemia (CLTI) have just been posted for open public comment until 3 December 2018. Michael S Conte (San Francisco, USA), one of the co-editors of the guidelines, told Vascular News...
 Artificial intelligence (AI) is already better than humans at reading specific radiographic findings. It will impact phycisians’ jobs, but because it can currently only do very specific things, it is not yet “that robot chasing you down a dark...
Michael Jaff (Newton, USA) outlines the major recent developments in best medical therapy that will impact the treatment of peripheral arterial disease (PAD) at VEITHsymposium 2018.
 Patrick Geraghty (St Louis, USA) presented new datapoints from the six-month outcomes of the Lutonix BTK IDE trial at the 2018 VEITHsymposium (13–17 November, New York, USA). In addition to the positive safety and efficacy data that were presented...
 Tilo Kölbel (Hamburg, Germany, and co-director of Aortic Live) tells Vascular News about the recently installed fusion imaging system from Cydar Medical, which connects live images from the operating room to the power of cloud computing. Kölbel shares his...
Six-month outcomes of the Lutonix BTK IDE trial, a multicentre randomised controlled trial using the Lutonix 014 drug-coated balloon (DCB; BD), has demonstrated that the DCB is safe and effective to use for the treatment of narrowed or obstructed...
Stéphan Haulon (Université Paris Sud, France) tells Vascular News at Aortic Live 2018 in Essen, Germany, about a niche group of patients, i.e., those that have had prior open repair of the ascending aorta following an acute type A dissection, that are...
Thomas Zeller (Bad Krozingen, Germany) delves into data and design of the TOBA II (Tack Optimized Balloon Angioplasty II) trial with principal investigator William Gray (Philadelphia, USA) for Vascular News. Gray, who presented the one-year findings of TOBA II...
 “The best treatment for a 60-year-old man with an infrarenal abdominal aortic aneurysm that is above the threshold for intervention is arguably surgery based on the durability of this intervention. However, operating at this age (where open surgery is...
 Rachel Bell (Guy’s and St Thomas’ Hospital, London, UK) describes a variety of specialist surgical options to treat infection after endovascular aneurysm repair (EVAR), a relatively rare occurrence that can have devastating complications. She stresses the importance of dealing...
 Ronald L Dalman (Stanford, USA), vice president of the Society for Vascular Surgery, discusses how aligning an individual surgeon’s goals with those of the institution at which he/she is sited is important to counter the “epidemic” of burnout. Dalman...
 Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also called Lithoplasty) seeks to microfragment the calcium seen in the vessels of peripheral arterial disease...
 Andrew Klein (a consultant anaesthetist from Royal Papworth hospital in Cambridge, UK) tells Vascular News that research in cardiac surgery has shown that while the surgeon has a small, but important, effect on a patient’s outcome after surgery, it is the...
 Chronic exposure to low dose radiation, such as that experienced by operators who routinely perform endovascular aneurysm repair (EVAR), has biological effects that can be mitigated with the use of lead shielding for the legs. However, many vascular and...
 “The instructions for use (IFU) are not a clinical guideline, so trainees should really think about what the main considerations are when they are implanting devices in the aorta to create a durable repair,” said Tara Mastracci (Royal Free...
 Tobias Steinke (Dusseldorf, Germany) reported on the Lutonix Global arteriovenous (AV) Registry at CIRSE 2018 in Lisbon, Portugal. Lutonix Global AV Registry data add to real-world outcomes of using Lutonix DCB in AV access. Straight after the presentation, Steinke tells Vascular News about...
Andrew Holden (Auckland, News Zealand) interviews Stefan Mueller-Huelsbeck (Flensburg, Germany) to distil the key findings of the IMPERIAL trial one-year data that were presented for the very first time at CIRSE 2018 in Lisbon. In the randomised controlled trial, Eluvia,...
Tilo Kölbel (University Heart Center Hamburg, Germany) talks about the findings of the STEP collaboration, and why endovascular procedure operators perhaps are "not the best people to examine neurological outcome" in their patients. STEP is a multidisciplinary initiative which aims...
Sean Lyden of the Cleveland Clinic (Cleveland, USA) discusses Endologix' Ovation grafts and the use endovascular aneurysm repair (EVAR) in short neck and complex anatomies.
Marc Schermerhorn (Boston, USA) discusses the three-year results of an analysis on the long-term survival of Nellix EVAS system (Endologix) IDE trial patients vs. a cohort of EVAR patients. The study found that EVAS is associated with higher long-term...
Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
Colin Bicknell (Imperial College, London, UK) speaks to Vascular News about his experience of using EndoAnchors in thoracic endovascular aortic repair (TEVAR), sharing his tips and techniques.
Maria Antonella Ruffino spoke to Vascular News at LINC 2018 about the differences between mesh-covered stents and conventional devices in treatment of carotid artery disease, as well as the differences between currently available mesh-covered stents.
Andrew Holden spoke to Vascular News at LINC 2018 (Leipzig Interventional Course; 30 January–2 February, Leipzig, Germany) about the new data from the IN.PACT AV access trial and its significance, as well as Holden's experience with the drug-coated balloon...
Vascular News interviews Panos Kitrou, Patras University Hospital, Rio, Greece, on the interim data from the LUTONIX DCB AV registry trial. The data were presented at the Leipzig Interventional Course 2018 (LINC; 30 January-2 February, Leipzig, Germany). https://www.youtube.com/watch?v=g1xN3knVdw4  
At the recent Vascular Interventional Advances 2017 conference (VIVA; 11–14 September, Las Vegas, USA), Vascular News caught up with Philips' Atul Gupta (Global Chief Medical Officer, Image Guided Therapy) and Will Martin (Peripheral Segment Leader, Image Guided Therapy) to...
Vascular News interviews Fabrizio Fanelli, Rome, Italy, on the results of the IN.PACT Admiral drug-coated balloon (Medtronic) in long lesions, lesions with calcification, chronic total occlusions, and TASC C and D lesions. The data were presented at the Charing...
This year Gore is celebrating 20 years of experience and innovation in the aortic space. At the Charing Cross Symposium (25–28 April, London, UK) Michael Dake, Stanford, USA, spoke to Vascular News about this milestone and about how Gore...
At the 2017 Charing Cross Symposium (25–28 April, London, UK) Klaus Amendt presented six-month outcomes from the all-comers LOCOMOTIVE Registry, which is investigating the use of the VascuFlex Multi-LOC multiple stent delivery system (B Braun). Amendt explained to Vascular...
The Charing Cross Symposium 2017 held a special session on Thursday 27 April to remember Edward B Diethrich, who died in February. The cardiovascular surgeon, who was one of the endovascular pioneers, was the founder of the Arizona Heart...
The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up with Raghu Kolluri (OhioHealth Vascular Institute, Columbus, USA) who explained his experience with the system...
At LINC 2017 Vascular News spoke to Peter Schneider (Kaiser Foundation Hospital, Honolulu, Hawaii, USA) about the Tack endovascular system (Intact Vascular), an implant designed to repair dissection damage done to the arterial wall during angioplasty treatment with minimal stress to the...
At LINC 2017 (24–27 January, Leipzig, Germany), Luis Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented an update on the SUPERSUB trial, which is investigating the use of the Supera stent (Abbott Vascular) for subintimal recanalisation in critical...
The LUMINOR Registry is a real-world prospective multicentre study evaluating iVascular’s Luminor paclitaxel-eluting balloon for treating advanced limb ischaemia. Vascular News spoke to Vincent Riambau (Autonomous University of Barcelona, Barcelona, Spain), who presented an update on the Registry at...
The first US randomised controlled trial for drug-coated balloon use for arteriovenous fistula obstructions for 50 years, the Lutonix (Bard) IDE trial was a talking point of the 2017 LINC meeting (24–27 January, Leipzig, Germany). Scott Trerotola, who presented...
At LINC 2017 (24–27 January, Leipzig, Germany), Sean Lyden (Cleveland Clinic, Cleveland, USA) presented an update on the 12-month results of the European and US cohorts of the ILLUMENATE randomised controlled trials, which are investigating the use of the Stellarex...
Piotr Szopinski, Institute of Haematology and Transfusion Medicine, Warsaw, Poland, speaks to Vascular News at the 2016 VEITHSymposium about the development and use of the COLT endograft system (Jotec) for the treatment of thoracoabdominal aortic aneurysm. ...
Vascular News speaks to Mario Lachat, University of Zurich, Zurich, Switzerland, at the 2016 VEITHSymposium, about the concepts behind the Horizon and Nexus stent grafts (Endospan) and whether these translate to clinical success. ...
Michael Lichtenberg, Klinikum Arnsberg, Arnsberg, Germany, tells Vascular News about the Wingman CTO catheter—a new chronic total occlusions recanalisation device from ReFlow Medical used to cross long and difficult occlusions—explaining how it works, when it is suitable, and his...
Speaking to Vascular News, Tej Singh, El Camino Hospital, Mountain View, USA, discusses the new vascular flow device from Medistim, explaining why there is a need for a new intraoperative arterial flow measurement system and how its use has...
Santi Trimarchi, University of Milan, Policlinico San Donato IRCCS, Milan, Italy speaks to Vascular News at the 2016 VEITHsymposium about the latest data from the IRAD (International Registry of Acute Aortic Dissection) Registry, how to manage in-hospital complications in type...
In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses the progress of the IMPERIAL trial comparing the Eluvia (Boston Scientific) and Zilver PTX (Cook...
  Andrew Holden (Auckland City Hospital, Auckland, New Zealand) is one of the principal investigators of the Nellix EVAS FORWARD Global Registry. He explained to Vascular News what to consider when selecting abdominal aortic aneurysm patients for Nellix treatment, why...
Matt Thompson (Chief Medical Officer, Endologix) speaks to Vascular News about what plans he has in his new role and the place of the Endologix portfolio in the physician’s armamentarium. He also tells Vascular News where he sees Nellix...
  Speaking to Vascular News at the 2016 VEITHsymposium, Bob Mitchell (President, Endologix) discusses updated Nellix instructions for use and the potential of the endovascular aneurysm sealing (EVAS) system in chimney repair. Looking at the rest of the Endologix product...
Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted and how relevant it is for young and senior clinicians to present their research at...
Colin Bicknell, London, UK, interviews Matt Thompson, St George's Vascular Institute, London, UK, about EndoVascular Aneurysm Sealing (EVAS) and the one-year results from the EVAS FORWARD Global Registry with the Nellix device. https://youtu.be/ID-TxhwRfuY  
Ian Franklin, a member of the CX Programme Organising Board and director of the CX Venous Workshop, speaks about new technologies for the treatment of varicose veins and about how deep venous interventions have been incorporated to the CX...
Janet Powell, Imperial College, London, UK, is interviewed about the 12-month results of the IMPROVE trial, presented for the first time at CX 2015. The study compares open repair and an endovascular strategy for ruptured abdominal aortic aneurysms. https://youtu.be/0mBE6_pHUtU
Colin Bicknell, London, UK, interviews Michael Dake, Stanford, USA, discussing the use of, and early results for, the new GORE TAG Thoracic Branch Endoprosthesis device. https://youtu.be/tjjOru2c-lk
Ian Loftus, London, UK, interviews Rodney White, Torrance, USA about new techniques for reconstruction of the ascending aorta, including White’s experience with a new endovascular device. https://youtu.be/sOuXIBxzjUo
This video tells the story of one of the world’s most prominent heart surgeons, Edward Diethrich, and the career-altering health issues he has faced as a result of chronic, low-level exposure to ionising radiation through his work. https://youtu.be/rXgt0bF3GJM
Lars Lönn carries out a thoracic endovascular aortic repair procedure on the Mentice VIST-Lab simulator. He presents a case and provides tips and tricks in endovascular practice. https://youtu.be/pAUqltrOMPQ
Vascular surgeon Peter Gloviczki explains who should be watched for abdominal aortic aneurysms, how they are diagnosed and how surgery, which now includes a less invasive endovascular option, is improving survival rates. https://youtu.be/JBJ-_olH67I
Frank Veith, chairman of the VEITHsymposium, speaks to Vascular News about the hot topics presented in the scientific sessions at the recent congress in New York and describes new technologies featured at the conference. https://youtu.be/pdByFKAufBk
Klaus Linni, Salzburg, Austria, spoke to Vascular News about the early results from a randomised trial comparing the use of a bioabsorbable stent vs. thrombendarterectomy for the treatment of common femoral artery lesions. The data were presented at the...
Bruce Perler, professor of Surgery and vascular surgeon, John Hopkins Medicine, USA, speaks about the treatment options and preventative measures that can be taken in carotid artery disease and stroke patients. https://youtu.be/NE_ose_81Z0
Scott Stevens, Knoxville, USA, spoke about the durability of EVAR devices at the 35th CX Symposium (6-9 April 2013, London, UK). Stevens stated that going low profile should not compromise device performance. https://youtu.be/iEoG4kuI05Y
Zamaneh Kassiri, a professor in the Department of Physiology, University of Alberta, is investigating the role of a protein called TIMP3 in abdominal aortic aneurysms. https://youtu.be/AmeNAiGLXlk
https://youtu.be/ac_om5HCjvg
Patrick Peeters, chief Department Cardio-Vascular and Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium, speaks about the right mix to make bioabsorbable drug-eluting stents, potential benefits, and challenges in the peripheral and coronary arteries treatment.   https://youtu.be/kS9IwwSU6eo

Daniel Clair

Peter Schneider

Rachel Bell